Package 0527-4662-37

Brand: lisdexamfetamine dimesylate

Generic: lisdexamfetamine dimesylate
NDC Package

Package Facts

Identity

Package NDC 0527-4662-37
Digits Only 0527466237
Product NDC 0527-4662
Product ID 0527-4662_7ac942a6-689a-420b-87bf-dc59003400dc
Description

100 CAPSULE in 1 BOTTLE (0527-4662-37)

Marketing

Marketing Status
Marketed Since 2023-08-25
Brand lisdexamfetamine dimesylate
Generic lisdexamfetamine dimesylate
Sample Package No

Linked Drug Pages (1)

Lisdexamfetamine Dimesylate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "7ac942a6-689a-420b-87bf-dc59003400dc", "openfda": {"upc": ["0305274664379", "0305274666373", "0305274661378", "0305274665376", "0305274667370", "0305274663372"], "unii": ["SJT761GEGS"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850", "1593856"], "spl_set_id": ["2cedb4c2-1e40-4bc4-b9f4-127150c4afbd"], "manufacturer_name": ["Lannett Company, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (0527-4662-37)", "package_ndc": "0527-4662-37", "marketing_start_date": "20230825"}], "brand_name": "Lisdexamfetamine Dimesylate", "product_id": "0527-4662_7ac942a6-689a-420b-87bf-dc59003400dc", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "0527-4662", "dea_schedule": "CII", "generic_name": "Lisdexamfetamine Dimesylate", "labeler_name": "Lannett Company, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisdexamfetamine Dimesylate", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "20 mg/1"}], "application_number": "ANDA215802", "marketing_category": "ANDA", "marketing_start_date": "20230825", "listing_expiration_date": "20261231"}